Fintel reports that on September 19, 2023, CJS Securities initiated coverage of Stevanato Group (NYSE:STVN) with a Market Outperform recommendation.
Analyst Price Forecast Suggests 15.19% Upside
As of August 31, 2023, the average one-year price target for Stevanato Group is 34.73. The forecasts range from a low of 26.60 to a high of $38.85. The average price target represents an increase of 15.19% from its latest reported closing price of 30.15.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Stevanato Group is 1,061MM, an increase of 2.94%. The projected annual non-GAAP EPS is 0.56.
What is the Fund Sentiment?
There are 192 funds or institutions reporting positions in Stevanato Group. This is an increase of 12 owner(s) or 6.67% in the last quarter. Average portfolio weight of all funds dedicated to STVN is 0.39%, an increase of 18.07%. Total shares owned by institutions increased in the last three months by 11.95% to 45,486K shares. 
The put/call ratio of STVN is 9.45, indicating a bearish outlook.
What are Other Shareholders Doing?
Conestoga Capital Advisors holds 3,788K shares representing 1.43% ownership of the company. In its prior filing, the firm reported owning 3,537K shares, representing an increase of 6.62%. The firm increased its portfolio allocation in STVN by 26.91% over the last quarter.
Lazard Asset Management holds 3,052K shares representing 1.15% ownership of the company. In its prior filing, the firm reported owning 3,442K shares, representing a decrease of 12.78%. The firm increased its portfolio allocation in STVN by 191.32% over the last quarter.
Neuberger Berman Group holds 3,030K shares representing 1.14% ownership of the company. In its prior filing, the firm reported owning 1,780K shares, representing an increase of 41.26%. The firm increased its portfolio allocation in STVN by 105.21% over the last quarter.
CCASX – Conestoga Small Cap Fund Investors Class holds 2,171K shares representing 0.82% ownership of the company. In its prior filing, the firm reported owning 2,051K shares, representing an increase of 5.52%. The firm increased its portfolio allocation in STVN by 24.85% over the last quarter.
NBGNX – Neuberger Berman Genesis Fund Investor Class holds 2,089K shares representing 0.79% ownership of the company. In its prior filing, the firm reported owning 658K shares, representing an increase of 68.48%. The firm increased its portfolio allocation in STVN by 329.84% over the last quarter.
Stevanato Group Background Information
(This description is provided by the company.)
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
